Skip to content

COMPARING HEMODYNAMIC EFFECTS OF TWO DIFFERENT DRUG INFUSIONS AFTER SUBARACHNOID BLOCK IN PATIENTS UNDERGOING CESAREAN SECTION

COMPARISON OF NOREPINEPHRINE AND PHENYLEPHRINE INFUSIONS FOR MAINTENANCE OF HEMODYNAMICS FOLLOWING SUBARACHNOID BLOCK IN LOWER SEGMENT CESAREAN SECTION

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013430
Enrollment
200
Registered
2018-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PREGNANT FEMALES

Interventions

Intervention1: NOREPINEPHRINE: NOREPINEPHRINE IS POTENT ALPHA ADRENERGIC AGONIST WITH RELATIVELY WEAK AGONISTIC ACTIVITY AT BETA RECEPTORS..DOSE IS 5 microgram/ml STARTED AT AN INFUSION RATE OF 30 ml/

Sponsors

DAYANAND MEDICAL COLLEGE AND HOSPITAL LUDHIANA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I, II, III UNDERGOING ELECTIVE LOWER SEGMENT CESAREAN SECTION UNDER SUBARACHNOID BLOCK

Exclusion criteria

Exclusion criteria: 1. ONSET OF LABOUR 2. KNOWN FETAL ABNORMALITY 3. HYPERTENSION OR PREECLAMPSIA 4. CARDIOVASCULAR OR CEREBROVASCULAR DISEASE 5. RENAL IMPAIRMENT 6. ALLERGY TO ANY STUDY MEDICATION 7. WEIGHT LESS THAN 50 KG OR MORE THAN 100 KG 8. HEIGHT LESS THAN 140 cm OR MORE THAN 180 cm 9. TAKING MONOAMINE OXIDASE OR TRICYCLIC ANTIDEPRESSANTS 10. PRESENCE OF MESENTERIC OR PERIPHERAL VASCULAR THROMBOSIS

Design outcomes

Primary

MeasureTime frame
EPISODES OF HYPOTENSIONTimepoint: AT 1 MINUTE INTERVALUPTO TIME OF DELIVERY

Secondary

MeasureTime frame
1. INCIDENCE OF INTRAOPERATIVE NAUSEA AND VOMITING 2. TOTAL AMOUNT OF DRUG USED TILL TIME OF DELIVERY 3. EPISODES OF HYPERTENSION 4. INCIDENCE OF BRADYCARDIA 5. APGAR SCORE AT 1 AND 5 MINUTES 6. UMBLICAL CORD BLOOD GASES Timepoint: AT 1 MINUTE INTERVAL UPTO TIME OF DELIVERY

Countries

India

Contacts

Public ContactKANIKA GOEL

DAYANAND MEDICAL COLLEGE AND HOSPITAL

dranjugrewal@gmail.com9815482626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026